1. Home
  2. IPO
  • Vijaypd Ceutical
Vijaypd Ceutical Ltd

Vijaypd Ceutical IPO

  • Status: Closed
  • RHP:
  • ₹ 280,000 / 8000 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    07 Oct 2025

  • Listing Price

    ₹ 35.00

  • Listing Change

    0.00%

  • Last Traded Price

    ₹ 47.95

Vijaypd Ceutical IPO Details

  • Open Date

    29 Sep 2025

  • Close Date

    01 Oct 2025

  • Listing Date

    07 Oct 2025

  • IPO Price Range

    ₹ 35

  • IPO Size

    ₹ 19.25 Cr

  • Listing Exchange

    NSE SME

Open Free Demat Account

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

Vijaypd Ceutical IPO Timeline

Vijaypd Ceutical IPO Subscription Status

Last Updated: 01 October 2025 6:49 PM by 5paisa

Vijaypd Ceutical Limited distributes pharmaceutical and consumer products across India, providing medicines, vitamins, wellness tonics, diagnostic kits, personal care products, ayurvedic and cosmetic items.

Established in: October 1971

MD: Samit Madhukar Shah

Peers:

1. MedPlus Health Services Ltd

2. Entero Healthcare Solutions Ltd

Vijaypd Ceutical Objectives

1. Capital expenditure for construction of API/intermediates - ₹ 10.83 Cr
2. Repayment/prepayment of borrowings- ₹ 5.10 Cr
3. General corporate purposes

Vijaypd Ceutical IPO Size

Types Size
Total IPO Size ₹19.25 Cr
Offer For Sale -
Fresh Issue ₹19.25 Cr

Vijaypd Ceutical IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 8,000 2,80,000
Retail (Max) 2 8,000 2,80,000

Vijaypd Ceutical IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)*
NII (HNI) 1.86 26,08,000 48,44,000 16.95
Retail Investors 0.89 26,08,000 23,20,000 8.12
Total** 1.37 52,16,000 71,64,000 25.07

 

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY24 FY25
Revenue 48.77 54.33 106.81
EBITDA 1.32 4.87 8.59
PAT 0.18 1.65 4.80
Particulars (in Rs. Crores)] FY23 FY24 FY25
Total Assets 32.87 33.27 57.15
Share Capital 4.93 1.00 14.03
Total Borrowings 25.56 30.04 21.77
Particulars (in Rs. Crores FY23 FY24 FY25
Net Cash Generated From / (used in) operating activities 0.30 2.93 -7.89
Net Cash Generated From / (used in) investing activities -0.09 13.78 -0.55
Net Cash Generated From / (used in) financing activities -0.18 -2.86 -2.38
Net Increase (Decrease) In Cash And Cash Equivalents 0.03 13.85 -10.82


Strengths

1. Comprehensive portfolio of pharmaceutical, wellness, FMCG, and ayurvedic products.
2. Extensive distribution network serving 2,100+ pharmacies, clinics, and nursing homes.
3. Experienced management team with proven execution capabilities.
4. Regulatory compliance with FDA, FSSAI, and BMC certifications.

Weaknesses

1. Cash flow fluctuations observed in FY25 operations.
2. Limited geographic presence outside existing districts.
3. Dependence on third-party manufacturers for certain SKUs.
4. A small IPO size may limit immediate capital expansion.

Opportunities

1. Expanding demand for healthcare and wellness products in India.
2. Growth potential in retail pharmacy and clinical distribution network.
3. Increasing focus on preventive healthcare and lifestyle products.
4. Potential to expand into new districts and product segments.

Threats

1. Intense domestic and international competition in the pharma and FMCG sectors.
2. Vulnerability to regulatory changes affecting manufacturing and distribution.
3. Supply chain disruptions could impact product availability.
4. Rising raw material costs may affect profitability.

1. Comprehensive Product Portfolio: Medicines, wellness, FMCG, ayurvedic and cosmetic items
2. Strong Distribution Network: Serving 2,109+ pharmacies, clinics, and nursing homes
3. Experienced Management: Proven track record of execution
4. Growth Potential: Expanding healthcare and consumer goods demand
5. Regulatory Compliance: FDA, FSSAI, and BMC certifications

Vijaypd Ceutical operates in the pharmaceutical distribution and consumer goods market, which is expected to grow steadily due to rising healthcare demand, wellness awareness, and urbanisation. Its broad product range, regulatory compliance, and established distribution network position the company to leverage growth opportunities in India’s pharmaceutical and FMCG sectors.

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

The Vijaypd Ceutical IPO opens on September 29, 2025 and closes on October 1, 2025.

The issue size of Vijaypd Ceutical IPO is ₹19.25 Cr.

The Vijaypd Ceutical IPO price is fixed at ₹35 per share.

To apply for Vijaypd Ceutical IPO, follow the steps given below:

1. Log in to your 5paisa demat account and select the issue in the current IPO section    
2. Enter the number of lots and the price at which you wish to apply for the Vijaypd Ceutical IPO.    
3. Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

You will receive a mandate notification to block funds in your UPI app.  

Vijaypd Ceutical IPO has an application minimum of 8,000 shares with a minimum investment amount of ₹2,80,000.

Allotment of Vijaypd Ceutical IPO is expected on October 3, 2025.

Vijaypd Ceutical IPO is tentatively expected to be listed on October 7, 2025, on NSE SME.

Smart Horizon Capital Advisors Pvt. Ltd is the lead manager for Vijaypd Ceutical IPO.

Vijaypd Ceutical shall utilise their IPO proceedings for;

1. Capital expenditure for construction of API/intermediates - ₹ 10.83 Cr
2. Repayment/prepayment of borrowings- ₹ 5.10 Cr
3. General corporate purposes